[Pharmaceutical Bio News] Chabaitech and Novartis Korea to Establish 'Open Innovation Center' in Second Half of This Year
Chabaitech and Novartis Korea have signed a strategic MoU to establish an Open Innovation Center aimed at supporting biotech startups.
Regeneron Chooses Milan: Italy as a Strategic Hub for Biotechnological Innovation
Regeneron has opened a new office in Milan, solidifying Italy's status as a key destination for foreign biotech investments.
Breakthrough in the fight against cancer and dengue getting closer? Poles are looking for drugs and going to the stock exchange
A Polish biotech start-up, Vaxican, is nearing 4.5 million PLN in funding to advance innovative diagnostic and therapeutic methods against arboviruses, driven by rising health challenges and climate change.
Parkinson Diagnosis: World Innovation from the Vineyards
A biotech company from a German province aims to simplify and improve the reliability of Parkinson's diagnosis, supported by a notable Parkinson's patient.
F.A.Z. Exclusive: Biontech is looking for a new CEO primarily in the USA
Biontech is searching for a new CEO in the United States following the announcement of the founders' operational departure from the company.
F.A.S. Exclusive: BioNTech Investors Want to Invest in Şahin and Türeci's New Start-up
The founders of BioNTech, Uğur Şahin and Özlem Türeci, are stepping down from their executive roles to focus on a new start-up, with their investors Thomas and Andreas Strüngmann looking to support this venture.
Biontech: 'Heart and Brain'
Uğur Şahin and Özlem Türeci, the co-founders of Biotech company Biontech, will step down from their executive roles at the end of 2026 to start a new venture focused on mRNA and AI.
Trump administration’s embattled FDA vaccine chief ousted for the second time
Dr. Vinay Prasad, the FDA's vaccine chief, is leaving the agency for the second time in less than a year amid controversies surrounding vaccine approvals and biotech drugs.
China and Hong Kong should relax biotech listing rules, venture capitalist says
A venture capitalist suggests that China and Hong Kong should ease regulations surrounding biotech listings to attract foreign investment in the healthcare sector.
Only 200 thousand human brain cells manage to cope with playing a bloody cult game
Australian biotech startup Cortical Labs has successfully programmed 200,000 human brain cells to play the video game Doom, showcasing the potential for biological processors to outperform conventional silicon chips.
China biotech outlicensing tops US$52 billion in first 2 months after global deal surge
In the first two months of the year, China's biotech outlicensing has exceeded US$52 billion, driven by significant partnerships with multinational pharmaceutical companies.
The Biotech Scandal Affects Serious Companies, They Had to Raise Money Quickly Elsewhere
The cancellation of a questionable grant call has negatively impacted several top biotechnology startups in Slovakia, forcing them to seek alternative funding.
Vytenis Povilas Andriukaitis. Lithuania's Chance to Shape Europe's Direction in Biotechnology Races
Lithuania's upcoming presidency of the EU Council in 2027 presents a unique opportunity to influence European biotech policy and innovation.
Biotech key to Russia’s industrial sovereignty – Putin
President Putin emphasizes the strategic importance of biotechnology supported by AI for Russia's industrial sovereignty during the Future Technologies Forum in Moscow.
An executive and a magnate: Bioceres is embroiled in a legal battle with a pending bankruptcy request
Bioceres, a prominent biotech unicorn in Argentina, is now facing a legal dispute over management between its shareholders, resulting in a bankruptcy filing.
China’s biotech boom sends price of lab monkeys for drug tests climbing
The prices of laboratory monkeys in China for drug testing have surged dramatically, exceeding the average annual salary in the country.
Songdo International City’s Biopharmaceutical Production Capacity Surpasses 1 Million Liters Annually
The annual production capacity of biopharmaceuticals in Songdo International City has exceeded 1 million liters, marking significant growth due to new factories.
Capital injection: China backs AI drug makers in self-reliance drive
The Chinese government is significantly investing in AI drug manufacturers to foster self-reliance in the biotech sector, exemplified by METiS TechBio's success in funding and drug development.
8 dead in biotech workshop blast in central China
A blast at a biotechnology factory in Shanxi province, China, has resulted in eight fatalities and an investigation into the incident is underway.
Game-changing nose spray promises to stop flu in its tracks
Researchers developed a novel nasal spray loaded with antibodies that has shown potential to block flu infection in early tests on animals and humans.
How innovation is born at CES 2026: seven startups looking to the future
CES 2026 showcases innovative startups like BTRY, CytoAurora Biotech, and others, each pushing the boundaries of technology and sustainability.
The ‘biology winter’ thaws: why investors are piling into Hong Kong’s biotech IPOs
Investors are increasingly supporting biotech IPOs in Hong Kong due to a resurgence in licensing deals and positive post-IPO performance, driving expectations of continued momentum through 2026.